Trial · NCT02550717
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Intracranial bleeding among new users of low-dose Acetylsalicylic acid (ASA). | Up to 13 years | |
| Primary | Incidence of Upper gastrointestinal bleeding among new users of low-dose ASA. | Up to 13 years | |
| Primary | Incidence of Lower gastrointestinal bleeding among new users of low-dose ASA | Up to 13 years | |
| Primary | Time to Intracranial bleeding among new users of low-dose ASA | Up to 13 years | |
| Primary | Time to Upper gastrointestinal bleeding among new users of low-dose ASA | Up to 13 years | |
| Primary | Time to Lower gastrointestinal bleeding among new users of low-dose ASA | Up to 13 years | |
| Primary | Relative risk of Intracranial bleeding among new users of low dose ASA | Up to 13 years | Relative risk is calculated as incident rate ratio produced by dividing the incidence rate of the outcome of interest in the exposed category by the incidence rate of the outcome of interest in the unexposed. |
| Primary | Relative risk of Upper gastrointestinal bleeding among new users of low-dose ASA | Up to 13 years | Relative risk is calculated as incident rate ratio produced by dividing the incidence rate of the outcome of interest in the exposed category by the incidence rate of the outcome of interest in the unexposed. |
| Primary | Relative risk of Lower gastrointestinal bleeding among new users of low-dose ASA | Up to 13 years | Relative risk is calculated as incident rate ratio produced by dividing the incidence rate of the outcome of interest in the exposed category by the incidence rate of the outcome of interest in the unexposed. |
| Secondary | Relative risk of Intracranial bleeding associated with use of other medications. | Up to 13 years | Relative risk is calculated as incident rate ratio produced by dividing the incidence rate of the outcome of interest in the exposed category by the incidence rate of the outcome of interest in the unexposed.To estimate relative risk in users of other medications such as clopidogrel,oral anticoagulants, non-steroidal anti-inflammatory drugs (NSAIDs) and selective serotonin reuptake inhibitors (SSRIs), independently from use of low-dose ASA and concomitantly |
| Secondary | Relative risk of Upper gastrointestinal bleeding associated with use of other medications | Up to 13 years | Relative risk is calculated as incident rate ratio produced by dividing the incidence rate of the outcome of interest in the exposed category by the incidence rate of the outcome of interest in the unexposed.To estimate relative risk in users of other medications such as clopidogrel,oral anticoagulants, non-steroidal anti-inflammatory drugs (NSAIDs) and selective serotonin reuptake inhibitors (SSRIs), independently from use of low-dose ASA and concomitantly |
| Secondary | Relative risk of Lower gastrointestinal bleeding associated with use of other medications. | Up to 13 years | Relative risk is calculated as incident rate ratio produced by dividing the incidence rate of the outcome of interest in the exposed category by the incidence rate of the outcome of interest in the unexposed.To estimate relative risk in users of other medications such as clopidogrel,oral anticoagulants, non-steroidal anti-inflammatory drugs (NSAIDs) and selective serotonin reuptake inhibitors (SSRIs), independently from use of low-dose ASA and concomitantly |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02550717/registered